We are live on ! Find out more
PCM

Perkins Capital Management Portfolio holdings

AUM $133M
1-Year Est. Return 127.86%
This Fund
S&P 500
This Quarter Est. Return
+22.61%
1 Year Est. Return
+127.86%
3 Year Est. Return
+303.11%
5 Year Est. Return
+333.48%
10 Year Est. Return
AUM
$167M
AUM Growth
+$27M
Cap. Flow
+$12.7M
Cap. Flow %
7.6%
Top 10 Hldgs %
31.97%
Holding
144
New
17
Increased
44
Reduced
36
Closed
12

Top Buys

Rank Stock Value
1
VERO
Venus Concept
VERO
+$1.51M
2
FPAY
FlexShopper
FPAY
+$1.49M
3
IRIX icon
IRIDEX
IRIX
+$1.16M
4
SRTS icon
Sensus Healthcare
SRTS
+$1.09M
5
NTRA icon
Natera
NTRA
+$940K

Sector Composition

Rank Sector Weight
1 Healthcare 60.63%
2 Technology 11.46%
3 Industrials 6.55%
4 Communication Services 4.39%
5 Consumer Discretionary 3.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CYBE
26
DELISTED
Cyberoptics Corp
CYBE
$1.9M 1.14%
94,250
+18,900
+25% +$377K
ANIP icon
27
ANI Pharmaceuticals
ANIP
$1.83B
$1.86M 1.12%
32,950
+1,950
+6% +$119K
RMTI icon
28
Rockwell Medical
RMTI
$28M
$1.77M 1.06%
3,805
+69
+2% +$33.4K
VERO
29
DELISTED
Venus Concept
VERO
$1.73M 1.04%
+240
New +$1.51M
AFL icon
30
Aflac
AFL
$64.8B
$1.64M 0.98%
34,850
LAB icon
31
Standard BioTools
LAB
$351M
$1.64M 0.98%
218,500
+49,500
+29% +$352K
TGT icon
32
Target
TGT
$65.6B
$1.63M 0.98%
18,450
NTRA icon
33
Natera
NTRA
$38.6B
$1.54M 0.93%
64,500
+38,900
+152% +$940K
PFIE
34
DELISTED
Profire Energy, Inc
PFIE
$1.54M 0.92%
482,025
-3,500
-0.7% -$11.1K
ATRS
35
DELISTED
Antares Pharma, Inc.
ATRS
$1.46M 0.88%
435,000
+117,500
+37% +$363K
CGRN
36
DELISTED
Capstone Green Energy Corporation Common Stock
CGRN
$1.46M 0.87%
145,714
+30,500
+26% +$390K
DCI icon
37
Donaldson
DCI
$10.7B
$1.45M 0.87%
24,900
-1,250
-5% -$62.8K
IRIX icon
38
IRIDEX
IRIX
$14.5M
$1.45M 0.87%
227,950
+156,000
+217% +$1.16M
CVS icon
39
CVS Health
CVS
$134B
$1.43M 0.86%
18,200
+250
+1% +$17.9K
BBQ
40
DELISTED
BBQ Holdings, Inc. Common Stock
BBQ
$1.36M 0.82%
207,853
-16,611
-7% -$109K
BSX icon
41
Boston Scientific
BSX
$68.4B
$1.34M 0.81%
34,900
VYNT
42
DELISTED
Vyant Bio, Inc. Common Stock
VYNT
$1.34M 0.8%
8,582
+1,885
+28% +$279K
BREW
43
DELISTED
Craft Brew Alliance, Inc.
BREW
$1.28M 0.77%
78,200
+13,600
+21% +$257K
VG
44
DELISTED
Vonage Holdings Corporation
VG
$1.27M 0.76%
89,725
+900
+1% +$12.4K
HTGM
45
DELISTED
HTG Molecular Diagnostics, Inc. Common Stock
HTGM
$1.26M 0.76%
1,387
T icon
46
AT&T
T
$159B
$1.18M 0.71%
46,687
+662
+1% +$16.2K
IZEA icon
47
IZEA Worldwide
IZEA
$59.2M
$1.17M 0.7%
183,924
-22,975
-11% -$135K
BMY icon
48
Bristol-Myers Squibb
BMY
$132B
$1.15M 0.69%
18,500
-500
-3% -$29.7K
TBCH
49
Turtle Beach Corp
TBCH
$243M
$1.06M 0.63%
53,006
-5,576
-10% -$138K
EXPD icon
50
Expeditors International
EXPD
$21.8B
$1.03M 0.62%
14,000

Similar funds

Perkins Capital Management's Q3 2018 Portfolio in Review

As of Q3 2018, Perkins Capital Management held 144 positions worth $167M, up 19% from $140M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Perkins Capital Management deployed $12.7M of net new capital in Q3 2018, opening 17 new positions and adding to 44 existing holdings. Its largest new stake was Venus Concept: 240 shares worth $1.73M.

By sector, the portfolio is most concentrated in Healthcare at 61% of assets, up from 59% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Tactile Systems Technology, an estimated $1.09M trimmed.

  • Perkins Capital Management's largest Q3 2018 buy was Venus Concept: 240 shares worth $1.73M.
  • Perkins Capital Management added most to IRIDEX in Q3 2018, an estimated $1.16M increase.
  • Perkins Capital Management's biggest Q3 2018 reduction was Tactile Systems Technology, cutting an estimated $1.09M.
  • Perkins Capital Management fully exited Invuity, Inc in Q3 2018, selling an estimated $1.22M.
  • Perkins Capital Management's ten largest holdings make up 32% of its $167M portfolio in Q3 2018.
  • Perkins Capital Management opened 17 new positions and closed 12 in Q3 2018.
  • Perkins Capital Management's portfolio value rose 19% quarter-over-quarter to $167M.

Based on Perkins Capital Management's 13F filing for Q3 2018, filed 22 Oct 2018.